Atossa Therapeutics Announces Greg Weaver Provided Notice Of His Resignation As The Executive Vice President And CFO Effective Oct. 5
Portfolio Pulse from Benzinga Newsdesk
Atossa Therapeutics' Executive Vice President and CFO, Greg Weaver, has announced his resignation effective October 5, according to an SEC filing.
October 06, 2023 | 8:07 pm
News sentiment analysis
Sort by:
Descending
NEGATIVE IMPACT
Atossa Therapeutics' CFO, Greg Weaver, has resigned. This could potentially impact the company's financial management and strategy.
The resignation of a CFO can have significant implications for a company. The CFO is responsible for financial planning and record-keeping, as well as financial reporting to higher management. In the short term, this could create uncertainty and potentially negatively impact the stock price.
CONFIDENCE 90
IMPORTANCE 75
RELEVANCE 100